8-142911899-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000498.3(CYP11B2):​c.*81G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 1,599,268 control chromosomes in the GnomAD database, including 59,115 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3912 hom., cov: 31)
Exomes 𝑓: 0.27 ( 55203 hom. )

Consequence

CYP11B2
NM_000498.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0500

Publications

17 publications found
Variant links:
Genes affected
CYP11B2 (HGNC:2592): (cytochrome P450 family 11 subfamily B member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 8-142911899-C-T is Benign according to our data. Variant chr8-142911899-C-T is described in ClinVar as Benign. ClinVar VariationId is 362191.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP11B2NM_000498.3 linkc.*81G>A 3_prime_UTR_variant Exon 9 of 9 ENST00000323110.2 NP_000489.3 P19099

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP11B2ENST00000323110.2 linkc.*81G>A 3_prime_UTR_variant Exon 9 of 9 1 NM_000498.3 ENSP00000325822.2 P19099
GMLENST00000522728.5 linkc.182-2064C>T intron_variant Intron 3 of 4 3 ENSP00000430799.1 E5RI31

Frequencies

GnomAD3 genomes
AF:
0.200
AC:
30343
AN:
151388
Hom.:
3917
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0528
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.0601
Gnomad SAS
AF:
0.187
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.220
Gnomad NFE
AF:
0.293
Gnomad OTH
AF:
0.196
GnomAD4 exome
AF:
0.269
AC:
389110
AN:
1447764
Hom.:
55203
Cov.:
30
AF XY:
0.267
AC XY:
192425
AN XY:
719620
show subpopulations
African (AFR)
AF:
0.0457
AC:
1520
AN:
33248
American (AMR)
AF:
0.138
AC:
5965
AN:
43098
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
6323
AN:
25680
East Asian (EAS)
AF:
0.0608
AC:
2395
AN:
39384
South Asian (SAS)
AF:
0.189
AC:
16091
AN:
85132
European-Finnish (FIN)
AF:
0.262
AC:
13772
AN:
52576
Middle Eastern (MID)
AF:
0.201
AC:
1064
AN:
5292
European-Non Finnish (NFE)
AF:
0.297
AC:
327219
AN:
1103556
Other (OTH)
AF:
0.247
AC:
14761
AN:
59798
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
14605
29209
43814
58418
73023
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10540
21080
31620
42160
52700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.200
AC:
30322
AN:
151504
Hom.:
3912
Cov.:
31
AF XY:
0.196
AC XY:
14477
AN XY:
74018
show subpopulations
African (AFR)
AF:
0.0526
AC:
2172
AN:
41262
American (AMR)
AF:
0.182
AC:
2779
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
854
AN:
3466
East Asian (EAS)
AF:
0.0605
AC:
306
AN:
5062
South Asian (SAS)
AF:
0.186
AC:
894
AN:
4798
European-Finnish (FIN)
AF:
0.265
AC:
2798
AN:
10562
Middle Eastern (MID)
AF:
0.216
AC:
63
AN:
292
European-Non Finnish (NFE)
AF:
0.293
AC:
19874
AN:
67798
Other (OTH)
AF:
0.193
AC:
405
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1161
2323
3484
4646
5807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.236
Hom.:
572
Bravo
AF:
0.188
Asia WGS
AF:
0.134
AC:
465
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Corticosterone methyloxidase type 2 deficiency Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Corticosterone 18-monooxygenase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Glucocorticoid-remediable aldosteronism Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
4.5
DANN
Benign
0.42
PhyloP100
0.050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3097; hg19: chr8-143993315; COSMIC: COSV59996750; API